| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,044 |
2,583 |
$938K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,841 |
3,660 |
$756K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,272 |
1,149 |
$152K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,428 |
910 |
$98K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,725 |
1,329 |
$85K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
717 |
450 |
$80K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
247 |
185 |
$66K |
| 71046 |
Radiologic examination, chest; 2 views |
1,363 |
1,277 |
$62K |
| 80061 |
Lipid panel |
2,645 |
2,638 |
$39K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,584 |
1,412 |
$37K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
534 |
362 |
$36K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
190 |
187 |
$35K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
984 |
835 |
$33K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,886 |
1,699 |
$33K |
| 80053 |
Comprehensive metabolic panel |
8,406 |
7,295 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,366 |
3,276 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
13,583 |
11,256 |
$25K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,261 |
381 |
$24K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
225 |
219 |
$23K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
176 |
127 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
343 |
327 |
$20K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
52 |
26 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,989 |
6,846 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,090 |
1,878 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
128 |
114 |
$16K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
234 |
234 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
521 |
474 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,154 |
1,877 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
364 |
348 |
$10K |
| 87430 |
|
1,092 |
1,059 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,615 |
1,608 |
$9K |
| 80306 |
|
833 |
730 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
13 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
13 |
$5K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
14 |
13 |
$4K |
| 87088 |
|
1,157 |
1,091 |
$4K |
| 85027 |
|
1,265 |
1,185 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
222 |
222 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
938 |
870 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
489 |
447 |
$3K |
| 83735 |
|
2,380 |
1,972 |
$2K |
| 81025 |
|
1,169 |
1,086 |
$2K |
| 84439 |
|
438 |
432 |
$2K |
| 87070 |
|
503 |
485 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
128 |
128 |
$2K |
| 81003 |
|
2,944 |
2,742 |
$2K |
| 87077 |
|
496 |
475 |
$2K |
| 85610 |
|
2,317 |
1,859 |
$2K |
| 87503 |
|
236 |
198 |
$2K |
| 82728 |
|
234 |
230 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
86 |
84 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
802 |
687 |
$2K |
| 87186 |
|
293 |
280 |
$1K |
| 86140 |
|
1,683 |
1,512 |
$987.60 |
| 73630 |
|
45 |
42 |
$980.10 |
| 97161 |
|
25 |
25 |
$962.21 |
| 83880 |
|
292 |
275 |
$951.69 |
| 81001 |
|
1,191 |
1,094 |
$944.10 |
| 82607 |
|
103 |
103 |
$796.61 |
| 83690 |
|
1,351 |
1,193 |
$753.95 |
| 73564 |
|
14 |
13 |
$697.43 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$648.44 |
| 73030 |
|
14 |
13 |
$520.32 |
| 84145 |
|
819 |
725 |
$493.58 |
| 85730 |
|
1,224 |
1,099 |
$349.29 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
15 |
$338.52 |
| 73130 |
|
12 |
12 |
$262.04 |
| 82150 |
|
768 |
666 |
$221.02 |
| 82550 |
|
720 |
639 |
$203.03 |
| 86803 |
|
25 |
25 |
$195.62 |
| 83605 |
|
976 |
862 |
$191.01 |
| 82746 |
|
25 |
25 |
$179.87 |
| 84484 |
|
1,067 |
928 |
$137.41 |
| 87210 |
|
30 |
29 |
$116.04 |
| 84481 |
|
12 |
12 |
$114.66 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,106 |
1,042 |
$108.76 |
| 85651 |
|
52 |
52 |
$95.62 |
| 85379 |
|
159 |
153 |
$93.93 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$87.91 |
| 87807 |
|
21 |
21 |
$72.62 |
| 87340 |
|
12 |
12 |
$57.19 |
| 82248 |
|
20 |
12 |
$47.25 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
71 |
71 |
$34.58 |
| 86308 |
|
12 |
12 |
$29.25 |
| 82270 |
|
13 |
12 |
$28.99 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,918 |
2,259 |
$12.04 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,024 |
876 |
$8.75 |
| 87040 |
|
15 |
13 |
$6.48 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
121 |
102 |
$5.06 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
13 |
13 |
$0.03 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
905 |
853 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
108 |
100 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
12 |
12 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
107 |
94 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
54 |
50 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
17 |
14 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
20 |
13 |
$0.00 |